Open Access
Open access
volume 14 pages 100214

Calcium carbonate vaterite particles for drug delivery: Advances and challenges

Publication typeJournal Article
Publication date2022-06-01
scimago Q1
wos Q1
SJR1.649
CiteScore14.0
Impact factor8.0
ISSN25900498
General Materials Science
Mechanical Engineering
Abstract
The recent successful application of lipid-based nanoparticles as delivery vehicles in COVID-19 vaccines demonstrated the superior potential of nanoparticle-based technology for targeted drug delivery in biomedicine. Among novel, rapidly advancing delivery platforms, the inorganic nano/microparticles gradually reach new heights and attract well-deserved attention among scientists and clinicians. Calcium carbonate in its vaterite form is used as a biocompatible carrier for a progressively increasing number of biomedical applications. Its growing popularity is conferred by beneficial porosity of particles, high mechanical stability, biodegradability under certain physiological conditions, ability to provide a continuous steady release of bioactives, preferential safety profile, and low cost, which make calcium carbonate a suitable entity of highly efficacious formulations for controlled drug delivery and release. The focal point of the current review is the success of the recent vaterite applications in the delivery of various diagnostics and therapeutic drugs. The manuscript highlights the nuances of drug loading in vaterite particles, connecting it with particle morphology, size, and charge of the loaded molecules, payload concentration, mono- or multiple drug loading. The manuscript also depicts recent successful methods of increasing the loading capacity developed for vaterite carriers. In addition, the review describes the various administration routes for vaterite particles with bioactive payloads, which were reported in recent years. Special attention is given to the multi-drug-loaded vaterite particles (“molecular cocktails”) and reports on their successful delivery in vitro and in vivo . • Vaterite is a safe and multifaceted delivery platform for pharmaceutical biologics. • The loading protocol is specially designed for a particular bioactive compound. • Particle freezing, combined adsorption/centrifugation, or doping increase loading. • Vaterite nanoparticles can perform targeted drug delivery in cancer treatment. • CaCO 3 is an efficient delivery system for invasive and non-invasive administration.
Found 
Found 

Top-30

Journals

1
2
3
4
Journal of Physical Chemistry C
4 publications, 3.88%
Crystal Growth and Design
3 publications, 2.91%
International Journal of Molecular Sciences
3 publications, 2.91%
Pharmaceutics
3 publications, 2.91%
Materials Research Express
3 publications, 2.91%
Nanomaterials
2 publications, 1.94%
Frontiers in Bioengineering and Biotechnology
2 publications, 1.94%
ACS Applied Nano Materials
2 publications, 1.94%
Heliyon
2 publications, 1.94%
Crystallography Reports
2 publications, 1.94%
Cement and Concrete Research
2 publications, 1.94%
Journal of Materials Chemistry B
2 publications, 1.94%
Expert Opinion on Drug Delivery
2 publications, 1.94%
Кристаллография
2 publications, 1.94%
Molecular Cancer
2 publications, 1.94%
Cancer Nanotechnology
1 publication, 0.97%
Frontiers in Materials
1 publication, 0.97%
LWT - Food Science and Technology
1 publication, 0.97%
ACS Infectious Diseases
1 publication, 0.97%
Exploration
1 publication, 0.97%
Cancers
1 publication, 0.97%
Small
1 publication, 0.97%
Minerals
1 publication, 0.97%
Environmental Science and Pollution Research
1 publication, 0.97%
Separation and Purification Technology
1 publication, 0.97%
CrystEngComm
1 publication, 0.97%
Nature Communications
1 publication, 0.97%
Materials Advances
1 publication, 0.97%
Applied Sciences (Switzerland)
1 publication, 0.97%
ACS Omega
1 publication, 0.97%
1
2
3
4

Publishers

5
10
15
20
25
30
Elsevier
27 publications, 26.21%
Springer Nature
15 publications, 14.56%
MDPI
15 publications, 14.56%
American Chemical Society (ACS)
13 publications, 12.62%
Pleiades Publishing
7 publications, 6.8%
Wiley
6 publications, 5.83%
Royal Society of Chemistry (RSC)
6 publications, 5.83%
Taylor & Francis
4 publications, 3.88%
Frontiers Media S.A.
3 publications, 2.91%
IOP Publishing
3 publications, 2.91%
The Russian Academy of Sciences
2 publications, 1.94%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.97%
Public Library of Science (PLoS)
1 publication, 0.97%
5
10
15
20
25
30
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
103
Share
Cite this
GOST |
Cite this
GOST Copy
Trushina D. et al. Calcium carbonate vaterite particles for drug delivery: Advances and challenges // Materials Today Advances. 2022. Vol. 14. p. 100214.
GOST all authors (up to 50) Copy
Trushina D., Borodina T. N., Belyakov S., Antipina M. N. Calcium carbonate vaterite particles for drug delivery: Advances and challenges // Materials Today Advances. 2022. Vol. 14. p. 100214.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mtadv.2022.100214
UR - https://doi.org/10.1016/j.mtadv.2022.100214
TI - Calcium carbonate vaterite particles for drug delivery: Advances and challenges
T2 - Materials Today Advances
AU - Trushina, Daria
AU - Borodina, T N
AU - Belyakov, Sergei
AU - Antipina, Maria N.
PY - 2022
DA - 2022/06/01
PB - Elsevier
SP - 100214
VL - 14
PMID - 36785703
SN - 2590-0498
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2022_Trushina,
author = {Daria Trushina and T N Borodina and Sergei Belyakov and Maria N. Antipina},
title = {Calcium carbonate vaterite particles for drug delivery: Advances and challenges},
journal = {Materials Today Advances},
year = {2022},
volume = {14},
publisher = {Elsevier},
month = {jun},
url = {https://doi.org/10.1016/j.mtadv.2022.100214},
pages = {100214},
doi = {10.1016/j.mtadv.2022.100214}
}